Search studies using keywords
4,004 Studies in the database containing data with -log p ≥ 0 (showing 61-80)
Pages: 1 2 3 4 5 6 7 8 9 10 >>
No data sets (in No Studies) added to Browser
Identifier Name Phenotype(s) Total p-values Related citationsAdd data sets to Browser Related data
HGVST3952 plus GWAS of Serum uric acid levels 
  • Serum uric acid levels
3
HGVST3953 plus GWAS of Urinary sodium and potassium excretion 
  • Urinary potassium excretion
  • Urinary sodium excretion
63
HGVST3954 plus GWAS of Differential aging 
  • Differential aging (frontal cortex)
  • Differential aging in older adults (frontal cortex)
2
HGVST3955 plus GWAS of Gestational duration 
  • Gestational age at birth (child effect)
  • Early spontaneous preterm birth
  • Post-term birth
4
HGVST3956 plus GWAS of Number of alcoholic drinks required to feel an effect 
  • Number of alcoholic drinks required to feel an effect (long-term average)
  • Number of alcoholic drinks required to feel an effect (first five times drinking)
3
HGVST3926 plus GWAS of Corticosteroid response 
  • Asthma control x inhaled corticosteroid treatment interaction (2df)
1
HGVST3927 plus GWAS of Spontaneous preterm birth 
  • Spontaneous preterm birth with premature rupture of membranes
  • Gestational age at birth (child effect)
  • Early spontaneous preterm birth
  • Spontaneous preterm birth without premature rupture of membranes
  • Moderate-to-late spontaneous preterm birth
  • Spontaneous preterm birth (preterm birth)
105
HGVST3928 plus GWAS of Lung cancer 
  • Squamous cell lung carcinoma
  • Non-small cell lung cancer
  • Lung adenocarcinoma
37
HGVST3929 plus GWAS of Type 2 diabetes 
  • Type 2 diabetes
5
HGVST3930 plus GWAS of Non-muscle-invasive bladder cancer tumour size 
  • Non-muscle-invasive bladder cancer tumour size
1
HGVST3931 plus GWAS of Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease 
  • Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
  • Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
2
HGVST3932 plus GWAS of Alcohol dependence, heroin dependence and methamphetamine dependence 
  • Alcohol dependence or heroin dependence or methamphetamine dependence
3
HGVST3933 plus GWAS of Thyroid function 
  • Thyroid stimulating hormone levels
  • Free thyroxine concentration
17
HGVST3934 plus GWAS of Perception and intake of sweet substances 
  • Sucrose liking
  • Perceived intensity of aspartame
  • Perceived intensity of fructose
  • Perceived intensity of sweet substances
  • Intake of total sugars
  • Perceived intensity of glucose
  • Perceived intensity of sucrose
  • Perceived intensity of neohesperidin dihydrochalcone
  • Perceived sweetness of sucrose
  • Intake of sweets
134
HGVST3935 plus GWAS of Fish intake frequency 
  • Fish intake frequency
4
HGVST3936 plus GWAS of Skin pigmentation 
  • Skin pigmentation (conditioned on rs1426654 and rs35397)
  • Skin pigmentation
19
HGVST3937 plus GWAS of Stress sensitivity 
  • Stress sensitivity (neuroticism score x major depressive disorder status interaction)
21
HGVST3938 plus GWAS of Type 2 diabetes 
  • Type 2 diabetes
22
HGVST3939 plus GWAS of Psychological wellbeing 
  • Psychological wellbeing (depressiveness)
  • Psychological wellbeing (social role performance and self-confidence)
  • Psychological wellbeing index 3 (fatigue and loss of appetite)
  • Psychological wellbeing (health and vitality)
  • Psychological wellbeing index (total score)
  • Psychological wellbeing index 1 (lack of subjective wellbeing and health)
  • Psychological wellbeing index 12 (lack of enjoying daily life)
2
HGVST3940 plus GWAS of Anorexia nervosa 
  • Anorexia nervosa
8